Has Richard Bloy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,351 in general payments to Richard Bloy, MD across 124 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Bloy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Bloy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Bloy, MD

Obstetrics & Gynecology · Fort Myers, FLNPI 1215991559

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Merz North America, Inc. at 38.2% of the total. Reporting peaked in 2019 at $1,069 and has fallen 87.7% since, to $131 in 2025.

$3,351in general payments, 2019–2025

Across 124 payments — averaging $27.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$1K
AbbVie$1K
Galderma Laboratories, L.p.$358
Hologic Sales And Service, LLC$123
Progenics Pharmaceuticals, Inc.$82
Revance Therapeutics, Inc.$68
plus $247 from 10 others

What the payments were for

Food & beverage$3,28998%
Education$331%
Gifts$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	23	$1,278
AbbVie(2 entities)	62	$1,194
Galderma Laboratories, L.p.	17	$358
Hologic Sales And Service, LLC	6	$123
Progenics Pharmaceuticals, Inc.	1	$82
Revance Therapeutics, Inc.	2	$68
Mayne Pharma Commercial LLC	2	$40
Therapeuticsmd, Inc.	2	$36
Acella Pharmaceuticals, LLC	2	$30
Ascend Therapeutics US, LLC	1	$30
Sumitomo Pharma America, Inc.	1	$27
Exeltis, USA Inc.	1	$19
Lupin Inc.	1	$18
Idorsia Pharmaceuticals US Inc	1	$17
Myovant Sciences Inc.	1	$16
Agile Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$243
Orilissa$230
ASCLERA$117

How this compares

$3,351 in reported general payments places this provider in the 80th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida →

Medicare billing

Part B allowed, 2024

$38,194

Medicare patients

104

Services billed

237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ProgesteroneProgesterone, Micronized	36	$1,350
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet	11	$619
ValacyclovirValacyclovir Hcl	11	$109
Megestrol Acetate	13	$77
Zolpidem Tartrate	14	$58
Alprazolam	13	$52
Fluconazole	17	$46
Anastrozole	11	$31
Atorvastatin Calcium	13	$27

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Fort Myers

Jason CesarioFort Myers$68K
Kevin FleishmanFort Myers$65K
Claudia Rodriguez-ArredondoFort Myers$21K
Steven McCarusCelebration$2.3M
Elliot CazesTampa$725K
Charles BloomWinter Park$652K
Jay CohenPlantation$556K
Omar ZwainWinter Park$531K
Keith AquaWellington$473K
Jeffrey KotzenPalm Beach Gardens$413K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →